Patents by Inventor Laurelee Osborn

Laurelee Osborn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
    Publication number: 20070149769
    Abstract: Antibodies specific for ELAMs are disclosed.
    Type: Application
    Filed: June 6, 2006
    Publication date: June 28, 2007
    Inventors: Catherine Hession, Roy Lobb, Susan Goelz, Laurelee Osborn, Christopher Benjamin, Margaret Rosa
  • Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
    Publication number: 20030153731
    Abstract: DNA sequences encoding endothelial cell-leukocyte adhesion molecules ELAMs, methods for producing such molecules, and ELAMs (including the specific molecules ELAM1 and VCAM1 and 1b) essentially free of normally associated animal proteins are disclosed. Antibodies against ELAMs are also disclosed.
    Type: Application
    Filed: September 3, 2002
    Publication date: August 14, 2003
    Inventors: Catherine A. Hession, Roy R. Lobb, Susan E. Goelz, Laurelee Osborn, Christopher D. Benjamin, Margaret D. Rosa
  • VCAM fusion proteins and DNA coding therefor
    Patent number: 6307025
    Abstract: VCAM fusion proteins capable of binding to VLA4, and DNA molecules coding on these fusions.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 23, 2001
    Assignee: Biogen, Inc.
    Inventors: Catherine A. Hession, Roy R. Lobb, Susan E. Goelz, Laurelee Osborn, Christopher D. Benjamin, Margaret D. Rosa
  • Vascular cell adhesion molecule (VCAM) polypeptides
    Patent number: 6252043
    Abstract: VCAM1 polypeptides and VCAM11/ICAM fusion proteins are disclosed.
    Type: Grant
    Filed: September 22, 1994
    Date of Patent: June 26, 2001
    Assignee: Biogen, Inc.
    Inventors: Catherine A. Hession, Roy R. Lobb, Susan E. Goelz, Laurelee Osborn, Christopher D. Benjamin, Margaret D. Rosa
  • Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
    Patent number: 5367056
    Abstract: DNA sequences encoding endothelial cell-leukocyte adhesion molecules ELAMs, methods for producing such molecules, and ELAMs (including the specific molecules ELAM1 and VLAM1 and 1b) essentially free of normally associated animal proteins are disclosed.DNA sequences encoding molecules involved in leukocyte adhesion (MILAs), methods for producing such molecules and MILAs (including the specific molecule, CDX) essentially free of normally associated animal proteins are also disclosed. Antibody preparations which are reactive for MILAs and also disclosed.Methods for identifying molecules which inhibit binding of leukocytes to endothelial cells, methods for inhibiting leukocyte binding to endothelial cells, and methods for detecting acute inflammation are disclosed.
    Type: Grant
    Filed: March 23, 1993
    Date of Patent: November 22, 1994
    Assignee: Biogen, Inc.
    Inventors: Catherine A. Hession, Roy R. Lobb, Susan E. Goelz, Laurelee Osborn, Christopher D. Benjamin, Margaret D. Rosa
  • DNA sequences encoding vascular cell adhesion molecules (VCAMS)
    Patent number: 5272263
    Abstract: DNA sequences encoding vascular cell adhesion molecules 1 and 1b ("VCAM1" and "VCAM1B"), recombinant DNA molecules comprising those sequences, and unicellular hosts transformed with those recombinant DNA molecules.
    Type: Grant
    Filed: December 18, 1989
    Date of Patent: December 21, 1993
    Assignee: Biogen, Inc.
    Inventors: Catherine A. Hession, Roy R. Lobb, Susan E. Goelz, Laurelee Osborn, Christopher D. Benjamin, Margaret D. Rosa